290 related articles for article (PubMed ID: 21232147)
1. Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy.
Sun D; Shen M; Li J; Li W; Zhang Y; Zhao L; Zhang Z; Yuan Y; Wang H; Cao F
Cardiovasc Diabetol; 2011 Jan; 10():4. PubMed ID: 21232147
[TBL] [Abstract][Full Text] [Related]
2. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J
Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
Wu W; Liu X; Han L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective role of GTS-21 by attenuating the TLR4/NF-κB pathway in streptozotocin-induced diabetic cardiomyopathy in rats.
Youssef ME; Abdelrazek HM; Moustafa YM
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jan; 394(1):11-31. PubMed ID: 32776158
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways.
Yin H; Chao L; Chao J
J Biol Chem; 2005 Mar; 280(9):8022-30. PubMed ID: 15611141
[TBL] [Abstract][Full Text] [Related]
6. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C
PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674
[TBL] [Abstract][Full Text] [Related]
7. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.
Yao YY; Yin H; Shen B; Smith RS; Liu Y; Gao L; Chao L; Chao J
Cardiovasc Res; 2008 Dec; 80(3):354-64. PubMed ID: 18689794
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway.
Wang Y; Li X; Wang X; Lau W; Wang Y; Xing Y; Zhang X; Ma X; Gao F
PLoS One; 2013; 8(8):e70956. PubMed ID: 23976968
[TBL] [Abstract][Full Text] [Related]
9. Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion.
Song JQ; Teng X; Cai Y; Tang CS; Qi YF
Apoptosis; 2009 Sep; 14(9):1061-9. PubMed ID: 19634012
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
11. Urocortin attenuates myocardial fibrosis in diabetic rats via the Akt/GSK-3β signaling pathway.
Liu X; Liu C; Li J; Zhang X; Song F; Xu J
Endocr Res; 2016 May; 41(2):148-57. PubMed ID: 26934363
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats.
Li H; Liu Z; Wang J; Wong GT; Cheung CW; Zhang L; Chen C; Xia Z; Irwin MG
Cardiovasc Diabetol; 2013 Sep; 12():133. PubMed ID: 24041262
[TBL] [Abstract][Full Text] [Related]
13. Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3β and p38α/MAPK in a rat model of diabetic cardiomyopathy.
Al-Damry NT; Attia HA; Al-Rasheed NM; Al-Rasheed NM; Mohamad RA; Al-Amin MA; Dizmiri N; Atteya M
Biomed Pharmacother; 2018 Nov; 107():347-358. PubMed ID: 30099338
[TBL] [Abstract][Full Text] [Related]
14. Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms.
Aragno M; Mastrocola R; Ghé C; Arnoletti E; Bassino E; Alloatti G; Muccioli G
Cardiovasc Diabetol; 2012 Oct; 11():129. PubMed ID: 23066908
[TBL] [Abstract][Full Text] [Related]
15. The protective effect of kaempferol on heart via the regulation of Nrf2, NF-κβ, and PI3K/Akt/GSK-3β signaling pathways in isoproterenol-induced heart failure in diabetic rats.
Zhang L; Guo Z; Wang Y; Geng J; Han S
Drug Dev Res; 2019 May; 80(3):294-309. PubMed ID: 30864233
[TBL] [Abstract][Full Text] [Related]
16. Role of PI3K/Akt/NF-κB and GSK-3β pathways in the rat model of cardiopulmonary bypass-related lung injury.
He M; Zhang Y; Xie F; Dou X; Han M; Zhang H
Biomed Pharmacother; 2018 Oct; 106():747-754. PubMed ID: 29990867
[TBL] [Abstract][Full Text] [Related]
17. Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetes.
Potier L; Waeckel L; Vincent MP; Chollet C; Gobeil F; Marre M; Bruneval P; Richer C; Roussel R; Alhenc-Gelas F; Bouby N
J Pharmacol Exp Ther; 2013 Jul; 346(1):23-30. PubMed ID: 23591995
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.
Das S; Wong R; Rajapakse N; Murphy E; Steenbergen C
Circ Res; 2008 Oct; 103(9):983-91. PubMed ID: 18802025
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of butin against ischemia/reperfusion-induced myocardial injury in diabetic mice: involvement of the AMPK/GSK-3β/Nrf2 signaling pathway.
Duan J; Guan Y; Mu F; Guo C; Zhang E; Yin Y; Wei G; Zhu Y; Cui J; Cao J; Weng Y; Wang Y; Xi M; Wen A
Sci Rep; 2017 Jan; 7():41491. PubMed ID: 28128361
[TBL] [Abstract][Full Text] [Related]
20. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
